Analyst firms · Raymond James · BDX
Raymond James BDX price target and rating history
Becton Dickinson and Company (BDX) · Health Care
Raymond James rates Becton Dickinson and Company (BDX) Mkt Perform with a $305 price target, as of its latest action on May 2, 2025. It has published 3 rating actions on BDX since March 2022, including 1 upgrade and 1 downgrade. Across 6 firms with a BDX price target in the last 12 months, the median target is $191.
- Current rating
- Mkt Perform
- Price target
- $305
- Median target, all firms
- $191
- Actions on BDX
- 3
Every Raymond James rating on BDX
- May 2, 2025
- Jul 24, 2023
- Mar 18, 2022
How other firms rate BDX
Each firm's latest rating and stated target in the last 12 months.
| Firm | Rating | Price target | Date |
|---|---|---|---|
| Wells Fargo | Overweight | $242 | Nov 6, 2026 |
| Wolfe Research | Outperform | Oct 20, 2026 | |
| UBS | Buy | $19 | Jul 28, 2026 |
| Evercore ISI | Outperform | $180 | May 4, 2026 |
| Goldman Sachs | Neutral | $167 | Apr 10, 2026 |
| Barclays | Overweight | $202 | Feb 10, 2026 |
| Citigroup | Buy | $233 | Feb 3, 2026 |
Questions about Raymond James and BDX
- What is Raymond James's price target for BDX?
- Raymond James's latest stated price target for Becton Dickinson and Company (BDX) is $305, from its action on Jul 24, 2023.
- What is Raymond James's rating on BDX?
- Raymond James rates BDX Mkt Perform, a neutral rating, as of May 2, 2025.
- When did Raymond James last change its view on BDX?
- On May 2, 2025, Raymond James downgrades to Mkt Perform from Outperform.
- How does Raymond James's BDX target compare with other analysts?
- Across 6 firms with a BDX price target in the last 12 months, the median target is $191.
More BDX rating histories
All Raymond James ratingsBDX news and filingsEvery analyst firm
From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.